Vinge’s Life Sciences & Health practice group offers business oriented legal advice for the biotechnology, pharmaceutical, healthcare, medical device, veterinary, cosmetics and food industries.
The lawyers at Vinge have extensive experience of the regulatory and commercial landscape inherent in the life sciences and health industries. We have experience from all stages of product development and commercialization – from start-up to commercial stage.
Whether you are a newly established biotechnology R&D company or a multinational pharmaceuticals group, a venture’s commercial success can be facilitated by support from advisors that understand the unique challenges life science companies face in securing financing, safeguarding intellectual property, establishing partnerships, licensing, bringing new products to market, etc.
Vinge handles matters for Swedish and international clients in the life sciences and health industries. Our clients are active in, inter alia, the pharmaceutical, biotech, medtech, veterinary, healthcare and cosmetic fields.
Our advice is based on many years’ experience, which we can tailor to suit each client’s needs. Clients value our combination of substantial legal expertise and experience of the industry when they need to make and implement business decisions.
Because we are a full‑service firm, we can support our clients in all their business law matters. We have a dedicated team that focuses on partnering, licensing, M&A and other commercial transactions specific to the life sciences industries. Our capabilities and broad knowledge give us the ability to take on and resolve complex disputes efficiently with tailor-made teams. We offer advice in connection with regulatory matters, and we also assist in contacts with supervisory authorities in relation to studies and market access issues.
‘Vinge has a great ability to provide the right team of lawyers to ensure that the client is provided with the highest standard of expertise in the various legal areas involved, while maintaining simple and effective communication with the client.’ Legal 500 2022